Please sign in to follow a disease.
Baby's first flu: study tracks immune memory from day one
NCT ID NCT05436184
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 1,500 healthy infants from birth to age 4 to understand how their first encounter with the flu—either through vaccination or natural infection—affects their immune system's response to later flu exposures. Pregnant mothers are enrolled before delivery, and their babies are monitored over time. The goal is to learn how early flu experiences shape long-term immunity, which could help design better flu vaccines for children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,500 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2019
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
We will seek to obtain a balanced temporal distribution of the cohort births to account for seasonal variations in influenza transmission patterns. We will seek to enroll 30 eligible women per month by posting advertisements via study flyers and brochures in the maternal clinics, social media, institutional wide emails, and each of the enrollment clinic sites. Our staff will screen pregnant women in clinic settings for inclusion/exclusion criteria and then consent and enroll those eligible to participate.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Mother pregnant and ≥ 34 weeks gestation and ≥ 18 yrs. of age * Plans to deliver at local hospital * Lives within designated home zip codes: * No plans to move outside study area within study timeframe * Cell phone that can be used for text messaging * Singleton live born infant, born ≥ 34 weeks gestational age (GA) Exclusion Criteria: * Fetal or infant death prior to maternal hospital discharge * Mother known to be infected with HIV based on medical records * Major congenital anomalies, prenatally diagnosed or other major disorder or anomaly as determined by the PI * Reported use of heroin, cocaine or methamphetamines during pregnancy * Adoptive infant * Enrolled in any investigational vaccine trial or other interventional randomized, clinical trial involving the mother or infant that the PI's deem to be in conflict with study outcomes
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Influenza are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45219, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Flu shot showdown: can anflu match vaxigrip in Moms-to-Be?
- When the immune system Can't fight back: tracking three respiratory viruses
- Flu's journey: scientists track how influenza passes between people
- Can a stronger flu shot boost immunity in older adults?
- A nudge in the mailbox: could a letter boost flu shots for millions at risk?
- Can a new pill shorten the flu?